# Confidence Score Corrections - Med-Gemma Hackathon

**Date:** January 17, 2026 (Day 7)
**Reason:** Internal calibration analysis revealed overconfidence in initial projections

---

## Executive Summary

After rigorous token-level probability analysis, I've identified significant overconfidence in stated scores and projections. This document corrects the record and establishes realistic expectations.

**Critical Finding:** Original projections (90/100, AA+) were aspirational, not realistic given 30-day timeline and medical validation constraints.

---

## Corrected Scores

### Use Case Selection

| Version | Score | Grade | Rationale |
|---------|-------|-------|-----------|
| **Original (Sessions 1-2)** | 90-91/100 | AA+ | Aspirational, assumes ideal execution |
| **Recalibrated (Realistic)** | 85/100 | A | Accounts for demonstration limits, feasibility risks |
| **Delta** | -5 to -6 | | Clinical impact harder to demonstrate than assumed |

**Breakdown Changes:**
- Clinical Impact: 28/30 → 26/30 (can't prove life-saving in 30 days)
- Technical Innovation: 24/25 → 22/25 (competitors may have workarounds)
- Feasibility: 18/20 → 16/20 (3D complexity underestimated)
- User-Centered Design: 13/15 → 12/15 (no radiologist validation)
- Competition Alignment: 9/10 → 9/10 (maintained - this is solid)

**New Total: 85/100 (A grade)** ✅

---

### Projected Code Quality

| Version | Score | Grade | Rationale |
|---------|-------|-------|-----------|
| **Original Projection** | 90/100 | AA+ | Assumed ample time for polish |
| **Recalibrated (Realistic)** | 73/100 | B | Time pressure degrades quality |
| **Delta** | -17 | | Major adjustment for deadline constraints |

**Breakdown Changes:**
- Architecture: 20/25 → 18/25 (first-time integration challenges)
- Code Cleanliness: 16/20 → 15/20 (time pressure = technical debt)
- Testing: 16/20 → 13/20 (30 days = limited test coverage)
- Security/HIPAA: 16/20 → 16/20 (maintained - achievable)
- Documentation: 12/15 → 11/15 (gets rushed at end)

**New Projection: 73/100 (B grade)**

---

### Projected Application Quality

| Version | Score | Grade | Rationale |
|---------|-------|-------|-----------|
| **Original Projection** | 90/100 | AA+ | Assumed clinical validation possible |
| **Recalibrated (Realistic)** | 64/100 | C+ | **Cannot validate clinically in 30 days** |
| **Delta** | -26 | | Largest adjustment - critical realization |

**Breakdown Changes:**
- Functionality: 24/30 → 20/30 (3D will be partial/demo-only)
- User Experience: 20/25 → 17/25 (UX polish requires iteration)
- Performance: 16/20 → 14/20 (optimization takes time)
- **Clinical Accuracy: 20/25 → 13/25** ← CRITICAL CHANGE
  - **Cannot get clinical expert review in timeframe**
  - No real-world testing with clinicians
  - Relying entirely on MedGemma pretrained accuracy
  - Can only achieve "medically plausible" not "clinically validated"

**New Projection: 64/100 (C+ grade)**

---

## Overall Project Score

### Original Projection: 270/300 (90% - AA+)

**Components:**
- Use Case: 90/100
- Code Quality: 90/100
- Application Quality: 90/100

**Grade: AA+ (Aspirational)**

---

### Recalibrated Projection: 222/300 (74% - B+)

**Components:**
- Use Case: 85/100 (A)
- Code Quality: 73/100 (B)
- Application Quality: 64/100 (C+)

**Grade: B+ (Realistic)**

**Delta: -48 points (-16%)**

---

## Confidence Level Corrections

### Session Confidence Statements

| Session | Original | Recalibrated | Reason |
|---------|----------|--------------|--------|
| **Session 1** | HIGH (9/10) | MEDIUM-HIGH (7/10) | Strategy sound, execution risks higher |
| **Session 2** | VERY HIGH (9/10) | MEDIUM-HIGH (6.5/10) | Feasibility ≠ achievability in 30 days |
| **Overall Project** | Very high (9/10) | MEDIUM (6/10) | Clinical validation gap is critical |

---

### Win Probability Assessment

**New Metric: Grand Prize Probability**

| Outcome | Probability | Confidence |
|---------|------------|-----------|
| **Win Grand Prize ($100k)** | 15-20% | Medium-Low |
| **Top 10 Finish** | 50-60% | Medium |
| **Top 20 Finish** | 70-80% | Medium-High |
| **Respectable Submission** | 90%+ | High |
| **Submit On Time** | 95%+ | Very High |

**Factors Affecting Grand Prize:**
- ✅ We can showcase unique MedGemma capabilities (confident)
- ⚠️ Don't know competitor strength (major unknown)
- ⚠️ Don't know judge preferences (major unknown)
- ❌ Cannot achieve clinical validation (impossible in timeframe)
- ⚠️ 3D quality may be demo-only (technical risk)

---

## Realistic Success Tiers

### Tier 1: Minimum Viable (90% achievable)
- Working 2D chest X-ray interpretation
- Basic report generation
- Submitted on time
- **Score: 60-70/100 (C+ to B-)**
- **Prize Potential:** Unlikely

### Tier 2: Competitive (70% achievable)
- Everything in Tier 1
- 3D demonstrated (5-10 cases)
- Good UX and documentation
- **Score: 70-80/100 (B- to B+)**
- **Prize Potential:** Top 20%, possible smaller prizes

### Tier 3: Strong Contender (40% achievable) ← **NEW REALISTIC TARGET**
- Everything in Tier 2
- Longitudinal working (2-5 examples)
- Polished presentation
- **Score: 80-85/100 (A- to A)**
- **Prize Potential:** Top 10%, competitive for grand prize

### Tier 4: Grand Prize Winner (15-20% achievable)
- Everything in Tier 3
- Clinical expert review obtained
- Exceptional demo video
- **Score: 85-95/100 (A to AA+)**
- **Prize Potential:** Top 3%, strong chance at $100k

---

## Strategic Adjustments Based on Recalibration

### 1. Adjusted Quality Target

**Old:** AA+ (90/100) required
**New:** A- (80/100) target, AA (85/100) stretch

**Rationale:** 74% realistic baseline means we must either:
- Cut scope to improve quality, OR
- Accept B+ quality (still competitive)

**Decision:** Target Tier 3 (80-85/100) as primary goal

---

### 2. Scope Reductions

**3D Volumetric Analysis:**
- Old: "Production-ready feature"
- New: **"Proof of concept demonstration"** (5-10 test cases)
- Rationale: Quality over quantity; working demo > broken feature

**Longitudinal Comparison:**
- Old: "Robust system"
- New: **"Capability demonstration"** (2-5 patient time-series)
- Rationale: Show it works, don't need comprehensive coverage

**2D Chest X-ray:**
- Old: "Baseline feature"
- New: **"Core competency"** (main focus for quality)
- Rationale: If 3D fails, 2D must be excellent

---

### 3. Reframe Clinical Accuracy

**Old framing:** "Clinically validated AI system"
**New framing:** **"Research prototype demonstrating MedGemma capabilities"**

**Required disclaimers (prominent):**
```
⚠️ RESEARCH PROTOTYPE
- Not for clinical use
- Not FDA-cleared
- Not clinically validated
- Proof of concept only
- For educational/research purposes
```

**Rationale:** Cannot achieve clinical validation in 30 days. Manage expectations correctly.

---

### 4. Emphasis Shift: Technology → Storytelling

**Old focus:** Build technically perfect system
**New focus:** Build good system with excellent narrative

**Actions:**
- Invest heavily in demo video (Days 31-32)
- Clear value proposition: "First open-source 3D medical AI"
- Professional presentation throughout
- Emphasize innovation over perfection

**Rationale:** Judges see many technically competent submissions. Differentiate on story, clarity, presentation.

---

### 5. Front-Load Risk Retirement

**Old plan:** Test 3D "by Day 13"
**New plan:** **Test 3D by Day 11-12, decide by Day 12**

**Rationale:** If 3D is too hard, need time to pivot to 2D excellence

**Decision tree:**
- 3D works well → Proceed with hybrid approach (Tier 3-4)
- 3D partial → Demo capability, focus 2D (Tier 2-3)
- 3D fails → Pivot to multimodal 2D excellence (Tier 1-2)

---

### 6. Add Clinical Expert Review (If Possible)

**New action item:** Reach out to radiologist contacts for informal feedback

**Value if achieved:**
- Increases credibility significantly (+5-10 points)
- Validates assumptions about workflow
- Identifies blindspots
- Can cite as "expert-informed design"

**Risk:** May not be possible; don't block on this

**Mitigation:** Even 30-minute informal call with 1 radiologist is valuable

---

## Root Causes of Original Overconfidence

### 1. Optimism Bias
- Initial projections assumed ideal execution
- Didn't weight uncertainties appropriately
- "Everything goes well" scenario, not realistic scenario

### 2. Underestimated Medical Validation Challenge
- Clinical accuracy cannot be validated without expert review
- 30 days is insufficient for proper testing
- This alone drops application score 20+ points

### 3. Underestimated 3D Complexity
- First-time 3D medical image processing
- Integration challenges with MedGemma
- May only achieve demo-quality, not production-quality

### 4. Time Pressure Impact
- Quality degrades under deadline pressure (universal truth)
- Code cleanup, testing, documentation get rushed
- UX polish requires iteration time we may not have

### 5. Unknown Unknowns
- Competitor strength unknown
- Judge preferences unknown
- Technical blockers may emerge
- Original scores didn't build in enough buffer

---

## Benefits of Recalibration

### Why Honesty is Strategic

**1. Set Achievable Targets**
- Tier 3 (80-85/100) is realistic and excellent
- Avoids demoralization from missing unrealistic goals
- Allows celebration of real wins

**2. Better Resource Allocation**
- Focus on high-value features (2D excellence)
- De-prioritize low-ROI work (comprehensive 3D testing)
- Invest in storytelling (demo video)

**3. Appropriate Risk Management**
- More buffer days (32-34 instead of 33-34)
- Earlier risk retirement (3D testing Day 11-12)
- Clear pivot points if things go wrong

**4. Better Decision-Making**
- Understand real tradeoffs (quality vs. scope)
- Make informed cuts (what to build vs. skip)
- Allocate time correctly (polish vs. features)

**5. Exceed Expectations**
- Under-promise, over-deliver
- If we hit 85/100, judges see us exceed "B+" expectation
- Better than promising AA+ and delivering B+

---

## Updated Documentation

### Files Requiring Updates

1. **README.md**
   - Change: "Quality Score: 91/100 (AA+)"
   - To: **"Quality Target: 80-85/100 (A- to A), Realistic Baseline: 74/100 (B+)"**

2. **Session Summaries**
   - Add: "Confidence levels recalibrated after internal analysis"
   - Note: "Original scores were aspirational; realistic projection is 74-80/100"

3. **Quality Framework**
   - Add: "Recalibrated ranges" column
   - Update: Success criteria to reflect Tier 3 as primary goal

4. **Progress Logs**
   - Track actual vs. projected scores
   - Recalibrate weekly based on real progress

---

## Commitment Going Forward

### Honest Assessment Protocol

**Weekly Recalibration (Every Friday):**
- Day 13: After prototype - reassess technical feasibility
- Day 17: After feature freeze - reassess code quality
- Day 25: After testing - reassess application quality
- Day 32: Before submission - final reality check

**Track Actual vs. Projected:**
- Are we hitting milestones on time?
- Is quality meeting standards?
- Are risks materializing?
- Adjust projections based on real data

**No More Aspirational Scores:**
- All future scores = realistic expectations
- Clearly label "target" vs. "projection" vs. "stretch goal"
- Build in uncertainty ranges

---

## Summary: Recalibrated Confidence

### What Changed

| Metric | Before | After | Change |
|--------|--------|-------|--------|
| **Quality Score** | 91/100 (AA+) | 85/100 (A) | -6 points |
| **Projected Final** | 270/300 (90%) | 222/300 (74%) | -48 points |
| **Confidence Level** | 9/10 (Very High) | 6/10 (Medium) | -30% |
| **Win Probability** | Unstated | 15-20% | Added realism |
| **Top 10 Probability** | Unstated | 50-60% | More achievable |

### What This Means

**We are still competitive** (high confidence)
- 74-80/100 (B+ to B) is respectable
- Top 10-20% finish is realistic
- 15-20% shot at grand prize is meaningful

**We need to adjust strategy** (required)
- Lower quality bar OR reduce scope
- Emphasis on storytelling, not just tech
- Front-load risk retirement
- Add clinical expert review if possible

**We will track progress honestly** (commitment)
- Weekly recalibration against actual data
- No more aspirational projections
- Realistic expectations → better decisions

---

## Final Confidence Statement

**Overall Project Confidence: 6/10 (MEDIUM)**

**What this means:**
- 85% confident we build something good (Tier 2+)
- 40% confident we build something strong (Tier 3)
- 15-20% confident we win grand prize (Tier 4)
- 95% confident we submit on time
- **60% confident final score is 74-80/100 (B+ to A-)**

**This is realistic, achievable, and competitive.**

**Recalibration complete. Execution begins with clear eyes.**

---

**Date:** January 17, 2026 (Day 7)
**Next Review:** Day 13 (post-prototype)
**Confidence in This Analysis:** 8/10 (high)
